Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • The Discussion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • The Discussion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2022 - Mental Daily. All Rights Reserved.
Health

Oxford’s COVID-19 vaccine is nearly half as effective as Pfizer’s vaccine

Staff Writer
Staff Writer 2 years ago
Updated 2021/05/13 at 10:51 AM
Share
SHARE

Upon the world’s first registered SARS-CoV-2 vaccine developed by Russian scientists, many pharmaceutical companies across the world have since conducted vigorous research to develop an effective vaccine for the recent coronavirus strain.

New research published in The Lancet uncovered that Oxford’s COVID-19 vaccine is less effective than previously thought, with an efficiency rate nearly half as much as Pfizer’s vaccine.

According to the publication, Oxford’s phase 3 trials demonstrated that their vaccine was close to 50 percent efficient at protecting against the disease only when given two full doses, while its protection rate, in general, was purportedly estimated at 70 percent for most, but not all patients.

The findings are a drastic difference in comparison to Pfizer’s vaccine, with a purported efficiency rate above 90 percent, nearly identical in terms of efficiency as Russia’s Sputnik V.

“The results presented in this report provide the key findings from our first interim analysis. In future analyses, with more data included as it becomes available, we will investigate differences in key subgroups such as older adults, various ethnicities, doses, timing of booster vaccines, and we will determine which immune responses equate to protection from infection or disease,” said Merryn Voysey, co-author of the study, in a press release.

“Control of the pandemic will only be achieved if the licensing, manufacturing and distribution of these vaccines can be achieved at an unprecedented scale and vaccination is rolled out to those who are vulnerable. Our findings indicate that our vaccine’s efficacy exceeds the thresholds set by health authorities and may have a potential public health impact,” the authors of the study claimed.

The study and its results were funded by numerous public health institutions and private foundations, including the pharmaceutical company involved in the creation of the vaccine.

Photo: Getty Images

You Might Also Like

COVID-19 may be linked to an increase in brain infections in children

Cigarette smokers who want to quit often end up vaping or smoking

WHO declares monkeypox outbreak a global public health emergency

Regular e-cigarette use on the rise despite lower use among young adults

New research addresses how infection may affect fetal brain development

TAGGED: COVID-19, epidemiology, Oxford University, Pfizer
Staff Writer December 8, 2020
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article Depressive symptoms in British children increased throughout the first COVID-19 lockdown
Next Article The psychedelic ibogaine may be useful for psychiatric disorders, including addiction

Recommended

Health

COVID-19 may be linked to an increase in brain infections in children

1 Min Read
Health

Cigarette smokers who want to quit often end up vaping or smoking

1 Min Read
Health

WHO declares monkeypox outbreak a global public health emergency

1 Min Read
Health

Regular e-cigarette use on the rise despite lower use among young adults

1 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • Terms & Conditions
  • Privacy Policy
Follow US

© 2022 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?